← Back to Trial

The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

Trial Locations

• CIUSSS du Saguenay-Lac-St-Jean/CSSS de Chicoutimi Chicoutimi, Quebec, Canada
  • Contact: Hugo Villeneuve, MD
• CISSS de la Montérégie-Centre - Hôpital Charles-LeMoyne Greenfield Park, Quebec, Canada
  • Contact: Genevieve Bujold
  • Contact: Marjorie Jolicoeur, MD
• CISSS de Laval - Hôpital de la Cité-de-la-santé de Laval Laval, Quebec, Canada
  • Contact: Solange Tremblay
  • Contact: Levon Igidbashian, MD
• CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • Contact: Josée Abi-Saad
  • Contact: Peter Vavassis, MD
• Jewish General Hospital, McGill University Montreal, Quebec, Canada
  • Contact: Ashley Feng, M.Sc. · 514-340-8222 Ext. 26510 · [email protected] (opens in new tab)
  • Contact: Tamim Niazi, MD
• MUHC - Cedars Cancer Center Montreal, Quebec, Canada
  • Contact: Marianna Perna
  • Contact: Luis Souhami, MD
• CHU - L'Hôtel-Dieu de Québec Québec, Quebec, Canada
  • Contact: Josée Allard
  • Contact: André-Guy Martin, MD
• CIUSSS de l'Estrie - Hôpital Fleurimont Sherbrooke, Quebec, Canada
  • Contact: Sophie Couture
  • Contact: Abdenour Nabid, MD
• CIUSSS de la Mauricie-et-du-centre-du Quebec - Centre hospitalier régional de Trois-Rivières Trois-Rivières, Quebec, Canada
  • Contact: Marie-Eve Caron
  • Contact: Linda-Suzanne Vincent, MD